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Pulmonary Aspergillosis in a Child with
Hyperimmunoglobulin E Syndrome
Pulmonary aspergillosis is uncommon in childhood but may be
encountered in immunocompromised patients. Hyperimmunoglo-
bulin E syndrome (HIE) is characterized by marked elevation in
the level of immunoglobulin E and recurrent deep-seated infec-
tions. We describe a patient with HIE who developed an aspergil-
loma in the upper lobe of the right lung. Although Staphylococcus
aureus , other gram-positive and gram-negative organisms, and
Candida species have frequently been isolated from patients with
HIE syndrome, infections with Aspergillus species occur very
rarely in these patients [1].
A 15-year-old boy was admitted to the pediatric ward with a
2-day history of cough followed by chest pain and dyspnea. His
medical history was characterized by several episodes of pneumo-
nia, suppurative otitis media, salmonella sepsis, staphylococcal Figure 1. CT scan of the chest of a patient with pulmonary aspergil-
skin infections, and ‘‘cold’’ abscesses. He had coarse facies and losis and hyperimmunoglobulin E syndrome shows right lung pneu-
pruritic dermatitis. Two years before presentation, he had had cryp- mothorax and a thickened cyst wall in the right upper lobe.
tococcal meningitis that resolved only after he had received pro-
longed specific antifungal therapy and a permanent myeloperito-
neal shunt had been inserted because of increased intracranial
ological examination showed lymphocytic interstitial infiltrationpressure.
with foam and giant cells in the alveolar sacs and pleura andOn admission, the patient’s temperature was 37.27C; pulse,
fibrosis of alveolar walls. The patient was treated with itracona-70/min; respirations, 40/min; and blood pressure, 120/75 mm Hg.
zole for 3 months. There were no postoperative complications.He had mild peripheral and perioral cyanosis. Breath sounds over
Although candida infections are relatively common in patientsthe right hemithorax were reduced, without wheezing or crepita-
with HIE syndrome, aspergillus infections are extremely rare [1].tions. Findings of the remainder of the physical examination were
To our knowledge, only one adult with HIE syndrome and anunremarkable.
aspergilloma has been described [2]. Aspergillus species can pro-Laboratory studies revealed the following values: erythrocyte
duce a wide spectrum of pulmonary diseases, ranging from inva-sedimentation rate, 80 mm/h; hemoglobin, 14.7 g/dL; WBCs,
sive disease in severely immunosuppressed patients to hypersensi-9,000/mm3 (67% neutrophils, 21% lymphocytes, 8% monocytes,
tivity reaction, such as allergic bronchopulmonary aspergillosis,and 4% eosinophils); and platelets, 267,000/mm3. Cultures of
in atopic patients [3].blood, urine, and sputum were all negative. A tuberculin test
Bronchial pulmonary aspergillosis may be asymptomatic, butwith 5 units of PPD was negative. Chest radiographs showed
when it is symptomatic, it usually presents as hemoptysis, chronicright pneumothorax with right lung atelectasis. The serum IgE
cough, and, less commonly, weight loss [4]. This infection tendslevel was 20,000 IU/mL (normal level, 50–150 IU/mL), and
to occur in patients with chronic lung disease; the most commonthe IgG level was 2,033 mg/dL (normal level, 600–1,800
underlying disease is tuberculosis.mg/dL). The results of other humoral and cellular immunity
Patients with bronchial aspergillomas are younger and have bet-studies were normal. The neutrophil chemotactic activity was
ter nutritional statuses and respiratory functions than patients who40% of the normal control.
have pulmonary and pleural lesions [5].A thoracic drain was placed, which resulted in expansion of
Even though our patient had recurrent pneumonia, he did notthe right lung. However, pneumothorax recurred on each of
have apparent chronic lung disease. He presented with cough,three attempts to remove the drain. The patient was treated with
pleuritic pain, and pneumothorax—a rare presentation. A. fumiga-cloxacillin (4 g/d), ceftazidime (4 g/d), and amikacin (800
tus was isolated from the cavitation, and the pleura was involvedmg/d) for 10 days, but his condition did not improve. A CT
in the disease. Despite the complicated course of cryptococcalscan of the chest showed right pneumothorax, thickening of the
meningitis in this immunocompromised patient, he did not developpleural walls, and a right upper-lobe cavitation, compatible with
invasive aspergillosis.the presence of a fungus ball (figure 1). Bronchoscopy was
There is no consensus that surgery is mandatory for treatmentperformed, followed by right upper lobectomy. A culture of
of aspergilloma, but surgical treatment of pulmonary or pleuraltissue from the cavity yielded Aspergillus fumig atus.Histopath-
aspergilloma is recommended for patients with recurrent severe
hemoptysis or life-threatening symptomatic manifestations [5, 6].
Postoperative outcome is much better for patients with bronchial
aspergilloma than for those with pulmonary and pleural aspergil-
Reprints or correspondence: Dr. B. Wolach, Department of Pediatrics, Meir
loma [7]. The operative risk is low for patients who are asymptom-General Hospital, 44281 Kfar Saba, Israel.
atic and have no underlying lung disease. Our patient was consid-
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ered at high operative risk because of his immunocompromisedq 1998 by The University of Chicago. All rights reserved.
1058–4838/98/2601–0043$03.00 status and pleuropulmonary involvement. On the other hand, he
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2. Hall RA, Salhany KE, Lebel E, Bavaria JE, Kaiser LR. Fungal pulmonarywas young, had good nutritional status, and had no underlying
abscess in an adult secondary to hyperimmunoglobulin E syndrome.lung disease, and the lesion was well circumscribed in the right
Ann Thorac Surg 1995;59:759–61.upper lobe.
3. Gefter WB. The spectrum of pulmonary aspergillosis. J Thorac ImagingPatients with inoperable aspergillomas or those with invasive
1992;7:56–74.
aspergillosis may be treated satisfactorily with amphothericin B 4. Etienne T, Spiliopoulos A, Megevand R. Pulmonary aspergilloma. Helv
or a combination of amphothericin B and 5-flucytosine. Recent Chir Acta 1990;57:337–42.
studies have described successful treatment of invasive aspergillo- 5. Massard G, Roeslin N, Wihlm JM, Dumont P, Witz JP, Morand G. Pleuro-
sis with lyposomal amphothericin B [8] and itraconazole [9, 10]. pulmonary aspergilloma: clinical spectrum and results of surgical treat-
ment. Ann Thorac Surg 1992;54:1159–64.
6. Glimp RA, Bayer AS. Pulmonary aspergilloma. Diagnostic and therapeutic
considerations. Arch Intern Med 1983;143:303–8.Baruch Wolach, Alon Eliakim, Giora Gottesman,
7. Daly RC, Pairolero PC, Piehler JM, Trastek VF, Payne WS, Bernatz
and Alon Yellin PE. Pulmonary aspergilloma: results of surgical treatment. J Thorac
Department of Pediatrics, Sapir Medical Center, Meir General Hospital, Cardiovasc Surg 1986;92:981–8.
Kfar Saba; and Department of Thoracic Surgery, Sheba Medical Center, 8. Richards EM, Apperley JF, Marcus RE. Successful use of lyposomae
Tel Hashomer, Tel-Aviv University Sackler School of Medicine, encapsulated amphothericin to treat invasive aspergillosis following fail-
Tel-Aviv, Israel ure of conventional amphothericin. Clin Lab Haematol 1992;14:
127–30.
9. Dupont B. Itraconazole therapy in aspergillosis: study of 49 patients. J
Am Acad Dermatol 1990;23:607–14.References
10. Milleron B, Roger V, Roux P, et al. Semi-invasive aspergillosis with
1. Leung DY, Geha RS. Clinical and immunologic aspects of hyperimmuno- involvement of the thoracic wall cured by itraconasole. Rev Pneumol
Clin 1990;46:175–7.globulin E syndrome. Hematol Oncol Clin North Am 1988;2:81–100.
fluconazole dose was increased to 200 mg/d; thus, she was referredCandida Endocarditis Following Percutaneous
to our hospital for further care.Transluminal Coronary Angioplasty
Physical examination on admission revealed fever (temperature,
38.67C) and tachycardia without any peripheral embolic signs in
Although percutaneous transluminal coronary angioplasty the eyes and oral cavity. The heartbeat was regular, with a splitting
(PTCA) is performed frequently, to our knowledge, it has not been of S1; a grade 2/6 systolic murmur was heard over the right and
associated with subsequent serious infection. We report a case of left upper sternal borders, with radiation to the neck. The chest
candida endocarditis that occurred after PTCA was performed. was clear without basal rales. Splinter hemorrhagic spots were
A 42-year-old female was admitted to the hospital with a found on the right 2nd and 4th fingers and the left 3rd finger, and
4-month history of fever. Five months before admission, she had Janeway lesions were seen over both palms. The right leg was cold
undergone emergent PTCA twice at a local hospital because of and tender to palpation, and the right pedal pulse was diminished.
acute myocardial infarction involving the right coronary artery. Findings of the remainder of the physical examination were unre-
She was discharged after 1 week of hospitalization. Two weeks markable.
later, she developed intermittent fever (temperature, £397C) in Four sets of cultures of blood obtained at admission all yielded
association with dizziness, black floaters, soreness over her right Candida parapsilosis. A transthoracic echocardiogram showed
leg, and pain on pressure over her nails. vegetations on the aortic valves, which were associated with mild
She was readmitted to the same hospital because of the persistent aortic regurgitation and mitral regurgitation. Left aortoiliac emboli-
fever, soreness over her right leg, and painful nails. Blood cultures zation was disclosed by a Doppler study of the lower extremities.
yielded Candida species, and nosocomial fungemia was diagnosed. Therapy with intravenous amphotericin B (0.5 mg/kg) was initiated
Oral fluconazole was prescribed at a dose of 100 mg/d, and she immediately on admission, and therapy with oral fluconazole was
was discharged 3 weeks later with instructions to continue taking discontinued.
oral fluconazole. The fever and the symptoms of painful nails and Aortic valve replacement with a mechanical valve (Carbomed-
right leg soreness subsided during hospitalization but recurred 2 ics, Austin, TX) and left aortoiliac embolectomy were performed
days after discharge. The fever persisted despite the fact that the on the 7th hospital day. Large vegetations were found over all
three leaflets of the aortic valve, but there was no significant aortic
valvular dilatation. Culture of the valve tissue yielded C. parap-
silosis and Candida albicans.
Intravenous amphotericin B was administered postoperatively
Reprints or correspondence: Dr. Jen-Hsien Wang, Section of Infectious Dis- at a dose of 0.5 mg/(kgrd) (total dose, 1,020 mg). The patient’s
eases, Department of Internal Medicine, Veterans General Hospital–Kaohsi-
postoperative clinical course was uncomplicated, and she was dis-ung, 386 Ta-Chung 1st Road, Kaohsiung, Taiwan 813, Republic of China.
charged and instructed to take oral fluconazole at a dose of 200
Clinical Infectious Diseases 1998;26:205–6
mg/d. Inflammatory activity was monitored by obtaining monthlyq 1998 by The University of Chicago. All rights reserved.
1058–4838/98/2601–0044$03.00 measurements of the erythrocyte sedimentation rate (ESR) and
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the C-reactive protein (CRP) level. Two months after discharge, cin B are mandatory and life-saving. Because the incidence of
relapse among patients with candida endocarditis is high, ampho-progressive elevation of the ESR and CRP level occurred, but the
tericin B should be given for 6–10 weeks after surgery [2]. Despitepatient did not have any symptoms. The dose of fluconazole was
such prolonged therapy, significant relapse rates may still be ob-increased to 400 mg/d and was gradually tapered 4 months later.
served, even years after surgery. Suppressive fluconazole therapyAfter receiving treatment for 1 year, she is well, and no relapses
may play an important role in the prevention of relapse; however,have occurred since therapy with fluconazole was discontinued.
the optimal dosage and duration of such therapy are as yet undeter-PTCA is a frequently performed procedure for achieving repa-
mined and require further study.tency of coronary arteries in patients with ischemic heart disease.
There have been no previous reports of any major infectious com-
Jen-Hsien Wang, Yung-Ching Liu, and Susan Shin-Jung Leeplications of PTCA. However, it is not difficult to envisage that
Section of Infectious Diseases, Department of Internal Medicine,damage to the endothelium may occur during PTCA; such damage
Veterans General Hospital–Kaohsiung, Kaohsiung, Taiwan,
is a predisposing factor for infective endocarditis. Candida species
Republic of China
are normal flora of the skin and have been recognized as major
pathogens in infections associated with indwelling catheters, and References
these organisms may very likely be associated with infections that
1. Reyes MP, Lerner AM. Endocarditis caused by Candida species. In: Bodeg
occur after PTCA is performed. The mortality rate associated with GP, Fainstein V, eds. Candidiasis. New York: Raven Press, 1985:
candida endocarditis is lowest with combined medical and surgical 203–9.
treatment, rather than either medical or surgical treatment alone 2. Galgiani JN, Stevens DA. Fungal endocarditis: need for guidelines in evalu-
ating therapy. J Thorac Cardiovasc Surg 1977;73:293–6.[1]. Immediate surgical intervention and treatment with amphoteri-
ceftriaxone. The antibiotic regimen was changed to that with imi-Successful Treatment of Enterobacter Meningitis with
penem (750 mg q6h) and amikacin and intraventricular gentamicin.Ciprofloxacin
The patient remained febrile and comatose. The CSF pleocytosis
abated initially; however, on the fourth day of therapy, the CSFWe recently encountered a patient who developed a postneuro-
culture was still positive. At that time, therapy with imipenem andsurgical Enterobacter aerogenes–induced ventriculitis, which
amikacin was discontinued, and iv TMP-SMZ (5 mg/kg q6h)failed to respond to initial treatment with imipenem and subsequent
was begun, in combination with intraventricular gentamicintreatment with trimethoprim-sulfamethoxazole (TMP-SMZ). How-
(10 mg daily).ever, there was a dramatic response and cure with ciprofloxacin.
The CSF culture became negative on the fourth day of therapyAlthough there have been two reports of the successful use of
with TMP-SMZ and gentamicin, but the patient’s neurologicalciprofloxacin for treatment of ventriculitis due to Enterobacter
status remained unchanged. On the seventh day of iv TMP-SMZspecies in infants [1, 2], to our knowledge, ours is the first report
and intrathecal gentamicin therapy, the CSF cell count revealedof successful treatment with ciprofloxacin for meningitis due to
new pleocytosis (WBCs increased from 10 to 146, 85% polymor-Enterobacter species in an adult.
phonuclear leukocytes), and the protein level was also increasedA 38-year-old female was admitted to the hospital with sudden
(from 46 to 242 mg/dL). The culture again yielded E. aerogenes.onset of severe retro-orbital pain, blurry vision, and neck stiffness.
TMP-SMZ and gentamicin therapy was discontinued, and theThe patient underwent a neurological workup, which revealed a large
antibiotic regimen was changed to iv ciprofloxacin (400 mg b.i.d.);subarachnoid hemorrhage; an arteriogram established the presence of
there was dramatic improvement in the patient’s mental status witha left vertebral artery aneurysm. A craniotomy with aneurysmal clip-
this therapy. Subsequent CSF cultures were negative. However,ping was performed. Four days after surgery, the patient became
the patient’s mental status never completely normalized; thus, aunresponsive and febrile. A CT scan of the brain revealed edema
ventriculo-peritoneal shunt was eventually placed, and she wasand hydrocephalus. A ventriculostomy was performed that revealed
discharged to a long-term care facility. Levels of ciprofloxacin incloudy CSF, and empirical therapy with ceftazidime and amikacin
the CSF were never determined; the MIC of ciprofloxacin for thewas started. Laboratory studies of the CSF revealed the following
isolate was 0.14 mg/mL.values: WBCs, 32,500/mm3 (with 95% polymorphonuclear leuko-
Gram-negative bacillary meningitis is a disease seen primarilycytes); RBCs, 3,100/mm3; glucose, 18 mg/dL (peripheral blood level,
in neurosurgical patients [3] and neonates [4]. Before the develop-150 mg/dL); and protein, 353 mg/dL.
ment of third-generation cephalosporins, treatment of this condi-Cultures of CSF yielded E. aerogenes. The organism was sus-
tion was difficult because many antibacterial agents could notceptible to ciprofloxacin, gentamicin, TMP-SMZ, and imipenem
achieve concentrations in the CSF sufficient to sterilize it. To solveand demonstrated intermediate susceptibility to cefotaxime and
this problem, intrathecal instillation of aminoglycosides has been
used [5]. However, this procedure produces undesirable side ef-
fects, and the lower pH of purulent CSF decreases aminoglycoside
activity. In addition, there is considerable risk for superinfection
Reprints or correspondence: Dr. Vincenzo Scotto D’Antuono, 2 Starsplitter
with daily instillation of aminoglycosides into the CSF.Court, Voorhees, New Jersey 08043.
The treatment of gram-negative bacillary meningitis has been
Clinical Infectious Diseases 1998;26:206–7
facilitated with use of the third-generation cephalosporins sinceq 1998 by The University of Chicago. All rights reserved.
1058–4838/98/2601–0045$03.00 they are very active against gram-negative organisms and penetra-
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tion into the CSF is excellent [6]. However, causative organisms common pathogens in adults, as well as meningitis due to Pseu-
domonas species [10].(Escherichia coli, Klebsiella pneumoniae, Pseudomonas aerugi-
In conclusion, if the isolate is resistant to b-lactams, then thenosa, Acinetobacter calcoaceticus, and Enterobacter cloacae) are
drug of choice may be TMP-SMZ for treatment of enterobacteroften acquired nosocomially and typically are resistant to multiple
meningitis. Ciprofloxacin may be an alternative agent if the isolateagents, as was the case in our patient.
is susceptible and the MIC is low. Further randomized studies areOther agents that may be useful in the treatment of gram-
needed to compare the efficacy of ciprofloxacin with standardnegative bacillary meningitis include imipenem, TMP-SMZ, and
agents and newer agents that can be used to treat this disease.ciprofloxacin. The use of TMP-SMZ has been emphasized as ther-
apy for gram-negative bacillary meningitis caused by Enterobacter
Vincenzo Scotto D’Antuono and Irving Brownspecies [7]. Ciprofloxacin has been shown to enter the CSF at
Department of Infectious Diseases, Robert Wood Johnson Universitylevels 6.5%–39% of the serum levels observed in patients with
Hospital, New Brunswick, New Jerseybacterial meningitis [8].
In 1989, Schonwald [9] reported effective treatment with ci-
Referencesprofloxacin in a group of 20 patients with gram-negative bacillary
meningitis. E. coli was the most common isolate. Only one patient 1. Goepp JG. Use of Ciprofloxacin in an infant with ventriculitis. J Pediatr
1992;121:303–5.had meningitis due to Enterobacter species, and the specifies of
2. Bannon MJ. Ciprofloxacin in neonatal Enterobacter cloacae septicemia.this case were not revealed so it was not clear if this patient failed
Arch Dis Child 1989;64:1388.to respond to treatment [9]. The MICs of ciprofloxacin for the
3. Buckwold FJ. Hospital acquired bacterial meningitis in neurosurgical pa-causative agents were determined and were found to be very low,
tients. J Neurosurg 1977;46:494–500.as in our case.
4. Rossomando E. Bacterial meningitis. Review of the literature and retro-
Newer agents such as cefipime and meropenem, although not
spective study of 208 cases observed. Minerva Pediatr 1994;46:
used in our patient, could have been used. Cefipime may have 193–200.
higher activity than the third-generation cephalosporins against 5. Corrado ML. Designing appropriate therapy in the treatment of gram
E. aerogenes and has been shown to be clinically successful in negative bacillary meningitis. JAMA 1982;248:71–4.
6. Cunha BA. Third generation cephalosporins: a review. Clin Ther 1992;the treatment of infants and children with meningitis caused by
14:616–52.common pathogens. However, there are no clinical data yet avail-
7. Wolff MA, Young CL, Ramphal R. Antibiotic therapy for enterobacterable with respect to treatment with cefipime in adults with menin-
meningitis: a retrospective review of 13 episodes and review of thegitis due to common pathogens or nosocomial gram-negative
literature. Clin Infect Dis 1993;16:772–7.
rods. Meropenem may have increased activity over imipenem for
8. Barsic B. Entry of Ciprofloxacin into cerebrospinal fluid during bacterial,
the treatment of infection due to E. aerogenes, and meropenem viral and tuberculous meningitis. Neurologia Croatica 1991;40:111–6.
appears to have a lower propensity for causing seizures than 9. Schonwald S. Brief report: Ciprofloxacin in the treatment of gram negative
imipenem. In addition, there are clinical data demonstrating the bacillary meningitis. Am J Med 1989;87:248S–249S.
10. Med Lett Drugs Ther 1996;38(983, 984):84–86, 88–90.efficacy of meropenem for treatment of meningitis caused by
level of £30 1 109/L [3]. Glucocorticoids and splenectomy haveElevation of Platelet Counts Associated with Indinavir
been the usual initial treatments. Treatment with zidovudine hasTreatment in Human Immunodeficiency Virus–Infected
also been associated with an elevation in platelet counts [4] andPatients
platelet production [5] in both thrombocytopenic and nonthrombo-
cytopenic HIV-infected patients; this agent has been recommendedThrombocytopenia is a common manifestation of HIV infection.
as the initial treatment of choice by some authors [6]. On the basisThere appear to be two distinct mechanisms responsible for throm-
of these considerations, we hypothesized that because of its potentbocytopenia in HIV infection; immune-mediated destruction of
antiretroviral activity, treatment with a protease inhibitor wouldplatelets and a defect in platelet production due to direct infection
be associated with an abatement of thrombocytopenia, particularlyof the megakaryocyte [1]. Platelet sequestration and immune-
in patients with advanced AIDS.mediated destruction appear to be more important early in HIV
To test the hypothesis that indinavir treatment, as a component
infection, whereas decreased platelet production appears to be pre-
of triple antiretroviral therapy, is associated with elevation of plate-
dominant in the advanced stages of AIDS [2]. Severe thrombocyto-
let counts, we performed a single-center retrospective analysis of
penia is accompanied by a risk of bleeding, and treatment of throm-
HIV-infected patients treated with indinavir at Designated AIDS
bocytopenia is recommended when platelet counts decrease to a
Care Center and the Comprehensive Hemophilia Treatment Center
of the SUNY Health Science Center at Syracuse. Inclusion criteria
were as follows: documented HIV positivity; indinavir treatment
for at least 2 weeks, and platelet counts available within 2 months
Reprints or correspondence: Dr. Thomas E. Coyle, Regional Oncology Cen- before initiation of indinavir treatment and for at least 2 weeks
ter, SUNY HSC at Syracuse, 750 East Adams Street, Syracuse, New York
after the initiation of therapy. Patients were excluded if they started13210.
receiving zidovudine therapy concurrently, if noncompliance with
Clinical Infectious Diseases 1998;26:207–8
their medications had been documented, if they were receivingq 1998 by The University of Chicago. All rights reserved.
1058–4838/98/2601–0046$03.00 other treatment for thrombocytopenia, or if they were receiving
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Table 1. Effects of indinavir on platelet counts of thrombocytopenic 0131 to /217 1 109/L). Eighteen patients were thrombocytope-
and nonthrombocytopenic HIV-seropositive patients. nic. Platelet counts increased for each of the 18 patients, from pre-
to postindinavir treatment, a mean increase of 56 1 109/L (range,
Platelet counts (1109/L) 6–1831 109/L). The mean increase in pre- to postindinavir platelet
counts for the 44 nonthrombocytopenic patients was 12 1 109/L
Preindinavir Postindinavir
(range, 0131 to /217 1 109/L); this difference was not statisti-
Patient groups treatment treatment P value
cally significant. There was a decrease in platelet counts for 20
nonthrombocytopenic patients and an increase for 24 of those pa-Thrombocytopenic
tients. The mean absolute CD4 cell count for the thrombocytopenic(n  18) 117 (86–145) 173 (95–302) .0002
group was 64/mL (range, 10–290 mL), as compared to 176/mLNonthrombocytopenic
(n  44) 240 (155–402) 252 (142–482) .10 (range, 10–650 mL) for the nonthrombocytopenic group
Total (P  .01).
(n  62) 204 (86–402) 229 (95–482) .001 We conclude that initiation of antiretroviral treatment with indi-
navir as part of combination therapy is associated with an increase
NOTE. Data are presented as mean (range).
in platelet counts in patients with mild-to-moderate thrombocyto-
penia due to HIV infection. Patients with thrombocytopenia ap-
peared to have more advanced disease, as evidenced by lower
other protease inhibitors concurrently. Data collected included gen- absolute CD4 cell counts. Because indinavir therapy did not in-
eral demographics, previous antiretroviral treatments, platelet crease the platelet count in nonthrombocytopenic patients signifi-
counts 0–2 months before initiation of indinavir treatment and all cantly, these observations suggest that indinavir may increase the
counts after the start of treatment, and absolute CD4 cell counts platelet count through its antiretroviral effects, rather than by a
before initiation of indinavir therapy. HIV viral loads were not nonspecific mechanism. The data obtained from our study provide
available for the majority of these patients. the rationale for a prospective trial of indinavir as part of combina-
Data were evaluated by comparing the last platelet count before tion antiretroviral therapy for patients with thrombocytopenia and
commencing indinavir therapy and the first count obtained ⁄2 advanced HIV infection.
weeks after initiation of treatment in each patient. The one-tailed
Student’s t test for paired samples was used to evaluate the data Lori J. Maness, Donald C. Blair, Nancy Newman,
for all patients included in the study as well as for a subgroup of and Thomas E. Coyle
patients identified as thrombocytopenic, defined as having preindi- SUNY Health Science Center at Syracuse, Syracuse, New York
navir platelet counts of150 1 109/L, and a subgroup comprising
the remainder of the patients identified as nonthrombocytopenic. References
The two-tailed unpaired Student’s t test for samples of unequal 1. Coyle TE. Hematologic complications of HIV infection and the acquired
variance was used to compare pretreatment absolute CD4 cell immunodeficiency syndrome. Med Clin North Am 1997;81:449–70.
counts between the thrombocytopenic and nonthrombocytopenic 2. Najean Y, Rain JD. The mechanism of thrombocytopenia in patients with
groups. HIV infection. J Lab Clin Med 1994;123:415–20.
3. Landonio G, Nosari A, Spinelli F, Vigorelli R, Caggese L, Schlacht I. HIV-Three hundred-forty charts were reviewed, and 62 patients met
related thrombocytopenia: four different clinical subsets. Haematologicathe inclusion criteria. All 62 patients received indinavir as part of
1992;77:398–401.a combination treatment regimen, which included zidovudine in
4. Montaner JS, Le T, Fanning M, et al. The effect of zidovudine on platelet45 patients (73%). The mean duration of prior zidovudine therapy
count in HIV-infected individuals. J Acquir Immune Defic Syndr 1990;was 15.7 months (range, 1–82 months). The mean times for ob-
3:565–70.
taining the preindinavir platelet counts and postindinavir platelet
5. Ballem PJ, Belzberg A, Devine DV, Lyster D, Spruston B, Chambers H.
counts were 1 month (range, 0–2 months) before the start of Kinetic studies of the mechanism of thrombocytopenia in patients with
protease inhibitor treatment and 2 months (range, 0.5–8 months) human immunodeficiency virus infection. N Engl J Med 1993;327:
after the start of treatment, respectively. 1779–84.
The results are summarized in table 1. The mean increase in 6. Oksenhendler E, Selimann M. HIV-related thrombocytopenia. Immunodefic
Rev 1990;2:221–31.platelet counts for both patient groups was 25 1 109/L (range,
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Occult Cytomegalovirus Infection of Marrow Stroma
A 50-year-old cytomegalovirus (CMV)-seropositive male
with chronic myelogenous leukemia in blast crisis received an
unrelated, one-antigen mismatched marrow transplant at a dose
of 5.2 1 108 cells/kg. The patient was conditioned with 120
mg/kg cyclophosphamide and 1,350 cGy of total body irradia-
tion. He received methotrexate and cyclosporine as prophylaxis
for graft-versus-host disease, and engraftment occurred on post-
transplantation day 21. On day 61 he became CMV pp65 antigen
positive, and treatment with ganciclovir (5 mg/kg every 12 hours
for 7 days followed by 5 mg [kgrd], 6 days per week) was
initiated. Therapy with granulocyte-colony stimulating factor
(G-CSF) was started on day 76 in response to a decline in the
absolute neutrophil count (ANC).
Serum became negative for antigenemia by day 103, and gan-
Figure 1. Detection of CMV gene products in stromal cells culturedciclovir therapy was discontinued; however, the ANC continu-
from a marrow aspirate obtained on posttransplantation day 137 fromously declined, and the marrow cellularity dropped from 100%
a 50-year-old male. Adherent stromal cells were stained in situ by
on day 125 to 33% on day 137. All cells were of donor origin, using a cocktail of fluoresceinated antibodies to CMV (green). The
and there was no evidence of relapse. The patient’s CMV blood photomicrograph was obtained by use of an inverted fluorescence
culture and pp65 antigenemia test were negative at this time. microscope with a direct camera attachment.
However, the day-137 marrow sample tested positive by use of
PCR for CMV DNA, and cultured marrow stromal cells ex-
pressed viral antigen and shed virus (figure 1). Consequently,
treatment with iv foscarnet (60 mg/kg every 8 hours), immuno- case, marrow suppression seems to have been caused by direct
globulin (500 mg/kg every other day), and G-CSF was started on infection of cells in the marrow microenvironment. Findings on
day 149. The ANC returned to normal, but the patient developed phase contrast microscopy of stromal cultures suggest that the
sinusitis due to Aspergillus species. Treatment with amphotericin infected cell is nonhematopoietic. The genotype of the CMV
B (1 mg/[kgrd]) was started on day 155. isolated from this patient encodes envelope glycoprotein B (gB)
On day 159, the patient developed bilateral infiltrates with in- type 4; this genotype is relatively rare, occurring in only 8% of
creasing pp65 antigenemia. Culture of a bronchoalveolar lavage renal transplant recipients and 9% of marrow transplant recipients
specimen yielded Candida albicans but was otherwise nondiagnos- [2, 3]. The gB type may be significant, given a recent observation
tic. The patient died on posttransplantation day 165 of respiratory that myelosuppression after marrow transplantation is more sig-
failure. nificantly associated with gB types 3 and 4 than with types 1 and
The potential etiologic role of CMV in this case of marrow 2 [4]. The fact that CMV may be detected in marrow stroma in
suppression is supported by the presence of viral DNA in marrow the absence of viremia or pp65 antigenemia is also in agreement
and by the detection of immediate early and late CMV gene prod- with the results of a recent study by Rasmussen et al. [5], who
ucts in cultured marrow stroma. The absence of human herpes showed that CMV gB4 is more common in sites other than leuko-
virus type 6 (HHV6) (another reportedly myelosuppressive virus) cytes.
and the patient’s hematopoietic response to specific antiviral treat- The observation that CMV-related myelosuppression can occur
ment provide additional support that marrow suppression was most in the setting of low systemic viral load suggests that viral causes
likely attributable to CMV. The fact that G-CSF, in combination of marrow failure may be underdiagnosed and, further, that a diag-
with antiviral therapy, resulted in a rapid response agrees with nostic evaluation of marrow, including PCR analysis, is indicated
the observation that G-CSF may be specifically downregulated in for neutropenic patients with a history of positive CMV serology
CMV-infected stroma [1]. before transplantation. Given that poor marrow function can be
CMV infection has long been associated with marrow suppres- fatal or can lead to secondary complications such as invasive fungal
sion, but the documentation of virus in marrow cells from patients or bacterial infections, effective treatment should be started early.
with marrow failure has been difficult to achieve. In the present
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isoniazid, rifampin, ethambutol, and pyrazinamide. The patientTuberculosis of the Thumb Following a Needlestick
was in good health and afebrile. No cubital or axillary satelliteInjury
adenopathies were found. A Mantoux test was positive (induration,
22 mm) as a result of recent contact with a workmate who hadLaboratory accidents involving needles and syringes are fre-
tuberculosis, and findings on a chest radiograph were normal.quent and amount to almost one quarter of reported laboratory
The technician was treated with 300 mg of isoniazid andaccidents [1]. The consequences can be dramatic and have become
600 mg of rifampin daily for 6 months. The condition of his thumbeven more so since the arrival of the AIDS epidemic. We present
improved slowly, and the pain progressively disappeared. No bonea case of localized tuberculosis of the thumb that occurred after a
involvement was observed. After 1 year, the technician had re-laboratory accident.
covered without sequelae from his needlestick accident.At the end of February 1995, a 38-year-old male technician
Cutaneous tissue can be affected by tuberculosis in differentreceived a cervical lymph node for microbiological analysis. The
ways [2]. Straight inoculation, as described in the present report,specimen came from an HIV-positive, severely immunocompro-
is rare. Infections due to close contact, such as fistulating tuber-mized patient (CD4/ lymphocyte count, 40/mm3) who had active
culous adenitis, are more frequent. Finally, hematogenous dis-pulmonary tuberculosis. A mycobacterial culture was requested.
semination during the course of miliary tuberculosis can alsoIn the laboratory, the lymph node was carefully ground, then
give rise to skin lesions that usually present as papular formsdecontaminated and inoculated into a radioactive BACTEC 12B
showing central crusts [3].bottle (Becton Dickinson, Cockeysville, MD) that was to be moni-
Infection with tuberculosis by direct injection is rare. The skin istored at regular intervals in a BACTEC 460 TB instrument bottle
naturally resistant to tuberculosis; therefore, a breach of the cutaneous(Becton Dickinson). An acid-fast stain of the specimen was
barrier is necessary to provoke infection [4]. This can occur followingstrongly positive for acid-fast bacilli. After 10 days, the growth
circumcision [5], tattooing [6], intramuscular injection [7], or mouth-index of the bottle had reached the value of 60, and the technician
to-mouth resuscitation [8]. To our knowledge, only one case has beentook a sample of a few milliliters of broth in a sterile syringe in
described where a syringe used on an HIV-positive patient withorder to inoculate a new BACTEC 12B bottle for a NAP (p-nitro-
tuberculosis caused an accidental infection [9]. In that case, a nursea-acetylamino-b-hydroxypropiophenone) test. While trying to in-
injured herself with the needle of a catheter removed from an HIV-sert the needle through the membrane of the bottle, the technician
positive patient with pulmonary tuberculosis.stuck it deeply into the tip of his left thumb, touching the bone.
The duration and the choice of treatment in cases of cutaneousHe accidentally injected a bolus of the liquid deeply into his finger.
tuberculosis cannot be based on data from large published series.Knowing about the risk of infection, he vigorously disinfected the
Therapy has to be adapted on the basis of the local epidemiologywound with povidone-iodine. Despite the relatively low risk of
of M. tuberculosis resistance patterns. The recommendations ofcontamination with HIV (the lymph node had been previously
the Medical Section of the American Lung Association for treat-decontaminated, and it had been incubated for 10 days after
ment of extrapulmonary tuberculosis are probably also valid forremoval), the technician was given prophylactic treatment with
cutaneous infections caused by inoculation. The therapeutic regi-zidovudine (250 mg b.i.d.) for 2 weeks. Tests for antibodies to
men comprises triple therapy with isoniazid, rifampin, and pyra-HIV were negative at 0, 3, and 6 months.
zinamide for 2 months, followed by dual therapy with isoniazidTen days later the technician felt numbness at the site of the
and rifampin for 4 months; thus, treatment is given for a total offormer wound. He found that a pinhead-sized pustule on an ery-
6 months [10].thematous base had replaced the punctiform lesion. He pierced the
pustule with a lancet and observed numerous acid-fast bacilli in a
Daniel Genne´ and Hans H. SiegristZiehl-Neelsen acid-fast stain.
Department of Internal Medicine, Hospital, La Chaux-de-Fonds; andThe acid-fast bacilli in the lymph node were identified as Myco-
Neuchaˆtel Institute of Microbiology, La Chaux-de-Fonds, Switzerlandbacterium tuberculosis; susceptibility tests showed that the organ-
isms were susceptible to the four principal antituberculous drugs—
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G,£0.06 mg/mL; ampicillin/sulbactam,£0.5 mg/mL; and cefo-Successful Treatment of Primary Actinomyces viscosus
taxime, £0.5 mg/mL.Endocarditis with Third-Generation Cephalosporins
The patient had a history of uvular edema and respiratory
distress associated with penicillin treatment 30 years before thisEndocarditis due to Actinomyces species in the absence of
episode; therefore, therapy with iv ceftizoxime (2 g q8h) wasany recognizable focus of infection elsewhere is extremely rare.
started. Dental examination and radiographs showed caries butPenicillin has been the standard treatment for this condition,
no acute dental infection. Four teeth were subsequently ex-but there are no clinical data on the use of alternative agents in
tracted. Subsequent physical examinations revealed an increasecases where penicillin cannot be used. I describe a case of
in the systolic murmur heard on admission (grade 1/6) to gradeendocarditis due to Actinomyces viscosus in a penicillin-allergic
3/6 and a new decrescendo diastolic murmur grade 3/6, bestpatient who was treated successfully with third-generation ceph-
heard over the aortic area and left sternal border, with radiationalosporins.
to the carotid arteries. A repeated two-dimensional transthoracicAn 81-year-old man with no history of valvular heart disease
echocardiogram and a transesophageal echocardiogram, per-presented with depressed mood, suicidal ideation, anorexia,
formed 1 day apart, each demonstrated moderate mitral regurgi-weight loss, and back pain. On physical examination he ap-
tation, a thickened aortic valve with moderate aortic insuffi-peared pale, and his temperature was 38.57C, his pulse was
ciency, and a 1-cm highly mobile echogenic structure attached104/min, and his blood pressure was 120/55 mm Hg. Fun-
to the aortic valve, suggestive of a vegetation (figure 1). Theduscopic examination was unremarkable. Examination of his
patient was treated with iv ceftizoxime for 8 weeks and thenmouth revealed poor dental hygiene. Cardiac examination re-
with iv ceftriaxone (2 g q24h) as an outpatient for 4 weeks.vealed a grade 1/6 systolic murmur heard at the apex. Abdomi-
Blood cultures performed several weeks after the end of antibi-nal examination was negative for splenomegaly. Examination
otic therapy were negative. The patient was doing well 1 yearof the extremities did not reveal any petechiae, splinter hemor-
after the initial episode. There was no clinical evidence of con-rhages, Osler’s nodes, or Janeway lesions; clubbing was not
gestive heart failure. His blood pressure remained in the rangeobserved. The remainder of the results of his physical examina-
of 120/55 mm Hg, with no decrease in his pulse pressure.tion were normal. Significant laboratory findings included the
Endocarditis caused by Actinomyces species is rare. Mostfollowing values: WBC count, 11,300/mm3 (80% polymorpho-
cases are due to direct extension from the pericardium [1]. Onlynuclear leukocytes); hemoglobin, 10.5 g/dL; platelet count,
eight other cases of actinomycotic endocarditis, for which a260,000/mm3; and erythrocyte sedimentation rate, 82 mm/h.
portal of entry cannot be identified, have been reported sinceUrinalysis revealed microscopic hematuria. Findings on an elec-
1939 [2]. The clinical features of all nine cases (including thistrocardiogram were normal. A transthoracic two-dimensional
case) are similar to those of bacterial endocarditis due to otherechocardiogram demonstrated trace mitral regurgitation; no
vegetations were detected. Two sets of blood cultures performed organisms.
1 day after admission yielded gram-positive bacilli after 4 days. Penicillin is the standard treatment for actinomycosis. For
These organisms, as well as isolates from two other sets of penicillin-allergic patients with other forms of actinomycosis,
blood cultures performed 6 days after admission, were identified tetracycline, doxycycline, minocycline, erythromycin, clinda-
as A. viscosus by use of the API An-IDENT system (bioMe´rieux mycin, cephalosporins, and chloramphenicol are suitable alter-
Vitek, Hazelwood, MO). The isolate produced catalase. MICs natives [3, 4]. There is little clinical information available with
48 hours after anaerobic incubation were as follows: penicillin respect to the newer antimicrobial agents, except for anecdotal
success with ceftriaxone [5] and imipenem [6, 7] for treatment
of actinomycosis other than endocarditis. Although use of third-
generation cephalosporins in penicillin-allergic individuals ap-
pears to present only a slightly increased risk for drug reactions,
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these agents should be used with extreme caution, particularlyDiseases, Bay Pines Veterans Administration Medical Center 111J, 10,000
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This is the first case of actinomycotic endocarditis treated suc-Clinical Infectious Diseases 1998;26:211–2
This article is in the public domain. cessfully with third-generation cephalosporins. The optimal dura-
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Figure 1. Transesophageal echocardiogram of a patient with aortic valve endocarditis due to Actinomyces viscosus. A, Aortic valve appears
thickened (arrow); B, a freely mobile echogenic structure is attached to the aortic valve, consistent with a vegetation (arrow).
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nosing pleural tuberculosis. Nevertheless, both methods have limi-Polymerase Chain Reaction for the Diagnosis of Pleural
tations. Staining is rapid, easy, and inexpensive but not very sensi-Tuberculosis in Immunocompromised and
tive. The results of culture are not available for many weeks.Immunocompetent Patients
However, PCR is a method that permits a quick diagnosis by the
amplification of specific DNA sequences, including even a singleTuberculous pleural effusion (PE) usually occurs secondary to
copy of a given DNA sequence.
an immunologic reaction by the pleura to scant bacilli. The diagno-
The aim of the present study was to evaluate the use of a PCR
sis of tuberculous PE is important because 60%–65% of patients assay of PF for diagnosing pleural tuberculosis in the clinical
with this condition will develop some other form of active tubercu- setting.
losis [1]. We prospectively studied 131 patients (88 males; mean age, 56.7
Acid-fast staining and cultures have traditionally been used to years [range, 15–91 years]) with PE who had been examined in our
identify Mycobacterium tuberculosis in pleural fluid (PF) for diag- service during the period January 1994 to December 1995. For a
diagnosis of tuberculous PE, at least one of the following criteria had
to be met: (A) a PF or tissue culture positive for M. tuberculosis;
(B) the presence of necrotizing granulomas in a pleural biopsy speci-
Reprints or correspondence: Dr. Victoria Villena, Servicio de men in the absence of other pleural granulomatous diseases; or (C)
NeumologıB a, Hospital 12 de Octubre, Carretera de AndalucıB a Km 5.4, 28041
a clinical picture suggestive of pleural tuberculosis in association withMadrid, Spain.
a high IFN-g level in PF [2]. Only patients with scant PF, precluding
Clinical Infectious Diseases 1998;26:212–4
pleural biopsy, who had favorable clinical courses after receivingq 1998 by The University of Chicago. All rights reserved.
1058–4838/98/2601–0049$03.00 antituberculous treatment were included in the third criterion.
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Table 1. Diagnostic methods used for patients with pleural tubercu- with colonic, adrenal, and vulvar carcinoma; and 15 with carcino-
losis. mas of unknown origin); 16 had parapneumonic effusions; 13 had
transudates; and 17 had other diagnoses (3 with uremic PE; 2 with
Patient no. MCPF MCPB Histology* IFNG HIV† PCR pancreatitis; 2 with systemic lupus erythematosus; 2 with trapped
lung; and 1 each with nontuberculous chylothorax, viral pleuroper-
1 /, 0 / / 50 ND /
icarditis, pulmonary embolism, rheumatic polymyalgia, hemotho-
2 / 0 / 50 0 /
rax, and postsurgery, posttraumatic, and postpartum PE).3 / / / 50 0 /
The diagnostic methods used for each patient are shown in4 / 0 0 7 / /
table 1. Acid-fast bacilli were not detected by auramine-rhodamine5 / 0, 0 0, 0 ND ND /
staining in any of the PF specimens.6 / / 0 ND / /
7 0, 0 0, / 0, / 86 0 0  The sensitivity (95% CI) of PCR was 0.42 (0.25–0.61), and the
8 / / / 81 ND / specificity was 0.99 (0.94–1). With use of mycobacterial culture
9 /, /, 0 /  / 278 0 0 of PF obtained during the first thoracentesis, a diagnosis was made
10 0, 0, /, / 0, 0, 0 0, 0, / 1,700 0 0 for 39% of the patients, and this percentage increased to 52% when
11 0 / / 16 0 0 both mycobacterial culture and PCR were performed. Histological
12 0, 0 / / 27 0 0
study of the first pleural biopsy specimen showed granulomas for
13 /, / 0 / 90 0 /
83% of patients, and this percentage increased to 93% when PCR14 0, / 0 / 59 ND 0
was also performed for more rapid diagnosis.15 / ND ND 82 ND /
The sensitivity of PCR, in accordance with the diagnostic16 / / / 201 ND 0
method used and HIV status, is shown in table 2. The 33 patients17 / ND ND 23 0 /
18 / 0 / 46 0 0 were classified in groups A (20 patients), B (12), or C (1), ac-
19 0, /, 0 ND ND 10 ND / cording to the diagnostic criteria for tuberculosis; if a patient had
20 0, 0 / / 131 ND 0 pleural granuloma and a culture of PF or tissue positive for
21 0 0 / 85 0 / M. tuberculosis, he or she was included in group A.
22 0, 0, 0 0  /  32 0 0 Only one patient with nontuberculous disease had a positive
23 0 0 / 74 / 0
PCR result; she was a 70-year-old woman for whom PF cytology
24 0 0 / 40 0 0
showed the presence of malignancy. Transbronchial biopsy per-25 0, 0 0 / 53 0 /
formed during bronchoscopy revealed adenocarcinoma. However,26 0 0 / 58 0 0
a Mantoux test was positive, and she had had a lung nodule with27 0 0 / 56 / 0
calcifications detected when transbronchial biopsy was performed28 0 0 / 16 0 0
29 0 0 / 199 0 0 4 years earlier.
30 0, 0, 0 0  /  19 0 0  Although PCR assay for the diagnosis of tuberculosis has been
31 0 0 / 16 / 0 widely studied in recent years, its clinical value has not been fully
32 0 0 / 56 / 0 determined. We agree with other authors [5–7] that PCR is more
33 0, 0 ND ND 35 / / sensitive than culture of PF with use of Lo¨wenstein-Jensen me-
NOTE. Multiple determinations are shown where performed; the first result
is the sample in which PCR was performed. IFNG  interferon g level in
pleural fluid (IU/mL); MCPB  mycobacterial culture of pleural biopsy speci-
men; MCPF  mycobacterial culture of pleural fluid; ND  not done.
Table 2. Sensitivity of PCR under different conditions for diagnos-* Presence of granulomas in pleural biopsy specimen.
ing pleural tuberculosis in 33 patients.† Serology for HIV.
Sensitivity
Variable (95% CI) P value*
Mycobacterial culture ofAn aliquot (500 mL) of decontaminated and fluidified product
pleural fluid (no.)†was centrifuged at 9,500g for 15 minutes. DNA was extracted by
Positive (13) 0.77 (0.46–0.95) .005a simple lysis procedure with use of 50 mL of lysis buffer con-
Negative (20) 0.20 (0.06–0.44)taining 100 mg/mL of proteinase K [3, 4]. Five microliters of lysate
Diagnostic group (no.)‡in a 1:10 water dilution was used for the PCR assay to overcome
Group A (20) 0.55 (0.32–0.77) .05
the action of potential PCR inhibitors [3]. All reactions were car-
Group B (12) 0.17 (0.02–0.48)
ried out as described previously [3, 4], with minor modifications. HIV serology (no.)
IFN-g was measured by immunoradiometric assay [2] of the Negative (18) 0.33 (0.13–0.59) NS
PF obtained during the first thoracentesis. The statistical signifi- Positive (7) 0.43 (0.10–0.82)
cance of differences in sensitivity was evaluated with the Fisher’s
NOTE. The overall sensitivity (95% CI) of PCR was 0.42 (0.25–0.61).exact test.
NS  not significant.Thirty-three of the 131 patients met the criteria for tuberculosis,
* Fisher’s exact test was used for comparisons.
and 52 had neoplasms (13 with bronchogenic carcinomas; 11 with † Mycobacterial culture of the pleural fluid sample on which PCR was per-
mesotheliomas; 3 each with breast and stomach carcinomas; 2 with formed.
‡ Based on diagnostic criteria for tuberculosis.ovarian carcinomas; 2 with non-Hodgkin’s lymphoma; one each
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dium. If both tests are performed, the diagnostic sensitivity in- Victoria Villena, Ma. Jose´ Rebollo, Jose Ma. Aguado,
Antonia Gala´n, Angel Lo´pez Encuentra,creases; therefore, this combination may be useful if pleural biopsy
is not feasible. In addition, in clinical practice the rapid diagnosis and Elia Palenque
Departments of Respiratory Medicine, Microbiology, and Infectiousof tuberculosis is desirable, and pleural histology is usually the
Diseases, Hospital Universitario 12 de Octubre, Madrid, Spainmost useful test. The use of PCR increased the sensitivity of pleural
biopsy, thus enabling determination of a diagnosis sooner in most
cases.
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son of two protocols. Thorax 1992;47:265–9.
As far as we know, the sensitivity of PCR assay of PF from
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The predicted mortality for these six patients was 100% [4].Rhabdomyolysis During the Subacute Stage of
The median plasma concentration of TNF-a was 562 pg/mLMeningococcal Sepsis
(range, 165–720 pg/mL; normal concentration, 94 { 22 pg/mL);
the median level of IL-1b was 120 pg/mL (range, 50–930 pg/mL;
Rhabdomyolysis secondary to fulminant meningococcal sepsis normal level, 55 { 18 pg/mL) [5]. In addition to anti-shock ther-
(FMS) has been reported in only one case report and one review apy, sodium bicarbonate, mannitol, or both were given to prevent
article [1,2]. However, according to our experience, this complica- myoglobinuria-induced renal failure. Five patients survived, and
tion may occur rather frequently. one patient died after 102 hours, when secondary renal failure had
From 1993 to 1996 we saw 34 patients with FMS in the intensive progressed.
care unit (ICU) of the University Hospital Nijmegen, Nijmegen, The CPK values for these patients were normal on admission.
the Netherlands. We observed the serum creatine phosphokinase After admission, however, the CPK values increased gradually to
(CPK) activity in 13 patients for 30 hours. Only two patients a median of 11,580 U/L (range, 7,314–33,100 U/L) at a median
had normal CPK values, four patients had mild rhabdomyolysis of 40 hours (range, 22.3–61.5 hours). Serum myoglobin levels
(maximum CPK values, 785–1,219 U/L), and six patients devel- increased to a median of 5,595 mg/L (range, 3,720–7,680 mg/L),
oped severe rhabdomyolysis (maximum CPK values, 5,000 and urinary myoglobin levels increased to a median of 148,000
U/L) [3]. We discuss the cases of these latter six patients further. mg/L (range, 26,900–154,800 mg/L).
The initial shock-related renal failure in these patients abated
within 1–2 days. However, on day 4, renal failure progressed to
anuria in the patient with the highest maximum CPK values. At
autopsy, extensive deposits of myoglobin in distal and collecting
Reprints or correspondence: Dr. Marcel van Deuren, Department of Internal tubules were seen (figure 1). Myoglobin was also observed in the
Medicine, University Hospital Nijmegen, P.O. Box 9101, 6500 HB Nijmegen,
cytoplasm and along the brush borders of proximal tubular cells.the Netherlands.
Rhabdomyolysis secondary to bacterial infections may be
Clinical Infectious Diseases 1998;26:214–5
caused by direct bacterial invasion, by cytokine-induced muscle-q 1998 by The University of Chicago. All rights reserved.
1058–4838/98/2601–0050$03.00 cell toxicity, or by muscle ischemia due to shock and diffuse
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of fluid balance in the subacute stage of FMS is critical, the devel-
opment of anuria during this stage poses a serious threat. Alkalin-
ization and promotion of osmotic diuresis may prevent renal failure
[10]. Thus, early recognition of this complication is warranted.
Marcel van Deuren, Chris Neeleman, Karel J. M. Assmann,
Jack F. M. Wetzels, and Jos W. M. van der Meer
Departments of General Internal Medicine, Intensive Care, Pathology,
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Figure 1. T2-weighted MRI shows a wide, confluent white-matter
lesion in the left parieto-occipital lobe of a patient with progressive
multifocal leukoencephalopathy and common variable immunodefi-
ciency. A, transverse image; B, sagittal image.
positive. An ELISA for antibodies to HIV and an assay for p24 immunity. The present case is unusual in that PML occurred in
the presence of demonstrable humoral defects alone. In antibody-antigen were negative; an assay for serum cytomegalovirus (CMV)
antigen pp65 was positive at a low titer (4/200,000 polymorphonu- deficient patients, chronic encephalitis due to echovirus is a partic-
ular threat [3–5]; in addition, PML may be associated with thisclear neutrophils), as determined by immunofluorescence assay.
Other laboratory studies revealed the following values: total blood kind of immunodeficiency.
lymphocyte count, 2,860/mm3; B lymphocyte count, 290/mm3
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345/mm3); CD8 lymphocyte count, 1,030/mm3 (mean [{SD] nor-
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biopsy specimen from his neck revealed abundant acid-fast bacilliLepromatous Leprosy in a Renal Transplant Recipient
(AFB). Histopathologic examination revealed granulomatous in-
flammation and numerous vacuole-containing macrophages in the
In 1995, an estimated 1.8 million cases of leprosy occurred
deeper dermis. A Fite stain was positive for abundant AFB in the
worldwide; most of them were concentrated in Southeast Asia,
macrophage vacuoles and in the dermis. Because the organisms
Africa, and the Americas [1]. With the exception of imported
did not grow in cultures of the skin biopsy specimen, the specimen
cases, leprosy is virtually absent in Canada, northern or western
was submitted to the Gillis W. Long Hansen’s Disease Center in
Europe, and the United States. There are 7,000 patients with
Carville, Louisiana, where a PCR assay for Mycobacterium leprae
leprosy in the United States; these patients are mostly immigrants
was performed; the assay was positive.
from Mexico, Southeast Asia, the Philippines, and the Caribbean.
Smears of skin specimens from both earlobes and from skin
The annual incidence of newly diagnosed cases in the United States
folds at the elbows and knees demonstrated a bacteriologic index
is 200 [2]. We used MEDLINE to search the English-language
of 2/ (at least one bacillus per high-power field) to 5/ (at least
literature published from 1966 to the present for case reports of
100 bacilli per high-power field) [3]. The patient was treated with
new-onset leprosy in organ-transplant recipients; however, we did
a modified regimen for multibacillary disease, as recommended
not find any such reports. We report a case of lepromatous leprosy
by the World Health Organization, consisting of dapsone (100 mg
in a renal-transplant recipient.
q.d.), clofazimine (50 mg q.d.), and rifampin (600 mg q.d.) [3].
A 25-year-old male who was born and lived in New Orleans
The patient has been receiving therapy for 3 months and has not
underwent cadaveric kidney transplantation in 1987 because of
had any disease reaction or extension. His eyebrows have started
acute tubular necrosis of unknown etiology. His HLA (human
to grow back, and the skin nodules have diminished in size.
leukocyte antigen) phenotypes were A (3,23), B (7,0), C (2, 7),
We thought this case was interesting for several reasons. First,
DR (1, 2), DQ (1, 0), and DRw (0,0). After transplantation
it represents the first report of new-onset leprosy in a transplant
there were no episodes of rejection, opportunistic infection, or
recipient. There is one previous report of the relapse of leprosy
malignancy. He came to our attention in February 1997, when he
following renal transplantation [4]. In view of the vulnerability of
developed multiple, nontender, nodular lesions that first appeared
transplant patients to mycobacterial infection, the rarity of leprosy
on his face and then spread to his neck, trunk, and extremities 2
in this population may result from the relative infrequency of organ
weeks before admission. He reported that, in retrospect, 6 months
transplantation in areas where M. leprae is endemic. In the future,
earlier he had noticed a few nontender bumps on his right cheek
infection with M. leprae may become more common in transplant
that had resolved with the application of antifungal cream. He also
recipients if organ transplantation becomes available in less devel-
gave a history of progressive loss of hair, beard, eyelashes, and
oped countries.
eyebrows over the past few weeks.
Second, there is the question of how the patient acquired this
The patient’s medical history was remarkable for hypertension
infection and why he developed the lepromatous form. M. leprae–
and multiple blood transfusions that had been administered in
specific phenoglycolic acid (PGL-1) has been found in soil in the
1986. He revealed that he had attended college in Baton Rouge,
vicinity of armadillos [5]. Since the patient had no direct contact
Louisiana, where he did gardening as part of the required curricu-
with armadillos, we postulate that he may have been exposed to
lum. It is noteworthy that on many occasions, he had observed free-
M. leprae while working with soil in Baton Rouge, an area where
living armadillos on the college grounds. He denied any history of
armadillos are indigenous [6]. The reason for the lepromatous
travel or contact with leprous persons, and he had no pets. There
manifestation of our patient’s disease is probably complex, involv-
was no family history of leprosy or similar skin disease. His immu-
ing an interplay between cell-mediated immunosuppression (via
nosuppressive regimen included cyclosporine (225 mg q.d.) and
interference by cyclosporine and prednisone with the TH1 and
prednisone (10 mg q.d.).
IL-2 immune responses) and a genetic predisposition [7,8]. It is
Physical examination did not reveal fever or palpable nerves,
noteworthy that this patient possesses HLA-DR2 and HLA-DQ1
and findings of the neurological examination were normal. Exami-
alleles, both of which are strongly associated with lepromatous
nation of the skin disclosed multiple, waxy, nontender, nodular
leprosy [8].
lesions on the face, neck, trunk, and extremities. Several scattered
Finally, this case illustrates the importance of including leprosy
areas of alopecia and loss of beard, eyebrows, and eyelashes were
in the differential diagnosis of unusual skin lesions in immunocom-
also present. Laboratory studies revealed a leukocyte count of
promised hosts. On the basis of the acid-fast smear results, we
20,700/mm3 with 92% polymorphonuclear neutrophils, a hemoglo-
initially suspected a disseminated infection due to a rapidly grow-
bin level of 7.7 g/dL, a creatinine level of 2.5 mg/dL, an albumin
ing mycobacterium, and we treated the patient accordingly. How-
level of 2.9 g/dL, a cyclosporine level of 121 ng/mL, and trace
ever, the fact that AFB from an AFB-smear-positive specimen did
proteinuria; findings on a chest radiograph were unremarkable.
not grow in culture, as well as the characteristic histopathology,
The patient declined HIV testing. A touch preparation of a skin
were clues to the proper diagnosis.
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obtained 1 month later during repeated bronchoscopy. No inguinalRegression of Invasive AIDS-Related Kaposi’s Sarcoma
lymphadenopathies were found on repeated examinations. All of theFollowing Antiretroviral Therapy
patient’s KS lesions remain in remission 5 months later.
Quantification of HIV-1 RNA and detection of KSHV were
Kaposi’s sarcoma (KS) is the most common neoplasm in pa- done as previously described [2, 5]. Eight weeks before the treat-
tients with AIDS [1]. The KS-associated herpesvirus (KSHV) and ment was started, human herpesvirus (HHV)-8 DNA sequences
the HIV-1 regulatory gene tat have been involved in the pathogene- were not detected. Nevertheless, 8 weeks after treatment was be-
sis of KS [2, 3]. gun, HHV-8 DNA sequences were detectable. The serum HIV-1
The enhanced immune response achieved with combined antiret- viral load was 28,150 copies/mL when the therapy was started.
roviral therapies has been shown to induce remission of certain The viral load remained 500 copies/mL from the fourth to the
AIDS-related events. We report, to our knowledge, the first case 20th week of therapy. The evolution of the CD4/ cell count is
of regression of invasive KS in a patient with AIDS who received shown in figure 1.
aggressive antiretroviral therapy. The use of systemic chemotherapy is limited in patients with
A 44-year-old heterosexual man who was infected with HIV-1 AIDS-related KS and advanced immunodeficiency because of the
was admitted to the hospital before starting antiretroviral treatment adverse effects [6]. Regression of cutaneous AIDS-related KS fol-
because of probable Pneumocystis carinii pneumonia. lowing antiretroviral therapy has been reported previously [7].
The patient had nodular and violaceous lesions on the face, chest, However, the present report represents the first case of regression
left palate, knee, and right arm. These lesions ranged from 0.5 cm of invasive KS following antiretroviral therapy.
to 3 cm in size and were confirmed to be KS by histopathologic A marked decrease in the HIV-1 viral load and an increase in
examination. Multiple and painful inguinal lymphadenopathies were the CD4/ cell count preceded the resolution of our patient’s grade
also found, but they were not biopsied. A chest radiograph demon- IV KS. This regression could be explained by several hypotheses.
strated a bilateral interstitial infiltrate. The CD4/ and CD8/ lympho- First, antiretroviral drugs could have a direct effect on the clearing
cyte counts were 124 1 106/L and 1,609 1 106/L, respectively. of the HHV-8 infection. However, in the present case, the HHV-
Fiberoptic bronchoscopy was performed because the patient’s 8 DNA was detected 8 weeks after treatment was started. This
condition did not improve despite treatment with trimethoprim- finding could be due to a large repopulation of immune cells,
sulfamethoxazole. Two raised and violaceous endobronchial tu- including B lymphocytes, that harbored HHV-8. Second, use of
mors in the segmental apical and the lobar left bronchi, suggestive a potent antiretroviral drug combination can result in dramatic
of KS, were visualized on bronchoscopy. Histopathologic exami-
nation of an endoscopic biopsy specimen from one of the endo-
bronchial lesions disclosed the typical features of KS.
This patient’s KS was classified as stage IV [4]. Treatment with
zidovudine (250 mg b.i.d.), didanosine (200 mg b.i.d.), stavudine
(40 mg b.i.d.), and the HIV-1 protease inhibitor saquinavir (600 mg
t.i.d.) was started. Twelve weeks later, therapy with didanosine was
changed to that with lamivudine (150 mg b.i.d.) because acute gout
developed. The mucocutaneous lesions regressed 20 weeks after the
antiretroviral therapy was started. The endobronchial tumors disap-
peared, as confirmed by examination of multiple biopsy specimens
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isoniazid, rifampin, and streptomycin. Treatment with isoniazid,Three Episodes of Tuberculosis—To Multidrug
rifampin, ethambutol, pyrazinamide, and ciprofloxacin was started;Resistance and Back to Susceptibility
therapy with the latter three drugs was continued for 12 months.
After she recovered, she traveled several times to India betweenWe report the case of a patient who had three episodes of tuber-
1990 and 1993 and subsequently worked as an assistant nurse atculosis; two of these episodes were due to resistant strains of
the University Hospital in Zurich. In the fall of 1995, she com-Mycobacterium tuberculosis, and one was due to a susceptible
plained of pain under the right scapula and developed a productivestrain.
cough, malaise, fever, and night sweats. An infiltrate was observedA 31-year-old Tibetan woman who was born in India developed
on a chest radiograph, and pulmonary TB with right-sided cervicalsmear-positive tuberculosis (TB) of the lung in 1987, 1990, and
lymphadenitis was diagnosed (episode 3). For the third time, cul-1995. Upon immigration to Switzerland in 1984, findings on her
tures were positive, but surprisingly, the M. tuberculosis isolatechest radiograph were normal. Three years later, progressive, cav-
was fully susceptible to all first-line drugs.ernous TB of the left upper lobe was diagnosed (episode 1).
This finding prompted us to study all isolates at the molecularM. tuberculosis was isolated from sputum and gastric fluid speci-
level to better understand this case. By using PvuII as the restrictionmens, and primary resistance to isoniazid was detected. The patient
enzyme and IS6110 as a probe [1], we found two different patternswas hospitalized and treated with isoniazid, rifampin, and pyra-
of restriction fragment length polymorphism (RFLP): the isolateszinamide for 2 months, followed by a regimen of rifampin and
recovered during episode 1 and episode 2 had identical DNA fin-ethambutol for 4 months. After 14 weeks of treatment, cultures
gerprints, whereas those recovered during episode 3 differed con-became negative.
siderably from the initial strains. On probing AluI-digested DNAAfter the patient recovered clinically, she traveled to India and
with the polymorphic GC-rich repetitive sequence [2], bandingNepal in 1989; however, upon her return in 1990, she developed
patterns for the isolates from episodes 1 and 2 were again founda cough and night sweats, and cavernous TB of the left upper lobe,
to differ from those of episode 3.
with laryngeal and endobronchial involvement, was diagnosed (ep-
On the basis of this case, three major conclusions can be drawn:
isode 2). The M. tuberculosis isolate proved to be resistant to
(1) Of the two episodes of TB in 1990 and 1995, only one was a
true relapse, probably caused by inadequate drug therapy. Con-
versely, episode 3 was due to exogenous reinfection. (2) Treatment
of TB after episode 2 was successful, as indicated by the significant
Reprints or correspondence: Dr. Gaby E. Pfyffer, Swiss National Center for improvement in the patient’s condition and the numerous culture-
Mycobacteria, Department of Medical Microbiology, University of Zurich,
negative follow-up specimens that were obtained. (3) A mixed-Gloriastrasse 30, 8028 Zurich, Switzerland.
strain infection during episode 3 can be safely ruled out, not only
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on account of the DNA fingerprinting results but also becauseq 1998 by The University of Chicago. All rights reserved.
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excludes the presence of the previous strains (resistant to isoniazid for TB control must be aimed primarily at minimizing transmis-
sion, i.e., eliminating M. tuberculosis in such environments.and to multiple drugs).
Since the strain recovered from the patient’s sister, who had
Gaby E. Pfyffer, Anni Stra¨ssle, Otto Bra¨ndli,active TB in 1984, was not available for typing, it is not clear
and Helena Shangwhether the patient became infected via her sister or whether she
Swiss National Center for Mycobacteria, Department of Medicalwas infected while living in Tibet. The latter scenario is quite
Microbiology, University of Zurich, Zurich; and Zu¨rcher Ho¨henkliniklikely, since the incidence of TB among Tibetan immigrants living
Wald, Faltigberg, Switzerland
in Switzerland is very high (384 cases per 100,000 persons;
P. Helbling, Swiss Federal Office of Public Health, personal com- References
munication). In addition, the time of reinfection with the fully
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Mycobacterium tuberculosis by DNA fingerprinting: recommendations
Exogenous reinfection has been demonstrated conclusively in
for standardized methodology. J Clin Microbiol 1993;31:406–9.
patients with advanced HIV infection [3], but such reinfection 2. Poulet S, Cole ST. Repeated DNA sequences in mycobacteria. Arch Micro-
has also been reported among immunocompetent individuals with biol 1995;163:79–86.
either alcoholism [4] or diabetes [5] as risk factors. The patient 3. Small PM, Shafer RW, Hopewell PC, et al. Exogenous reinfection with
multi-drug resistant Mycobacterium tuberculosis with advanced HIV in-described herein had neither underlying disease nor other known
fection. N Engl J Med 1993;328:1137–44.risk factors. To our knowledge, this is the first well-documented
4. Shafer RW, Singh SP, Larkin C, Small PM. Exogenous reinfection withcase demonstrating that both relapse of TB, with progression to
multi-drug resistant Mycobacterium tuberculosis in an immunocompetentmultidrug-resistant TB, followed by exogenous reinfection and
patient. Tuber Lung Dis 1995;76:575–7.
development of active disease within a short period (8 years) is
5. Turett GS, Fazal BA, Justman JE, Alland D, Duncalf RM, Telzak EE.
possible within the same patient. A history of frequent travel to Exogenous reinfection with multidrug-resistant Mycobacterium tubercu-
areas where TB is highly prevalent supports the assumption that losis. Clin Infect Dis 1997;24:513–4.
in such countries, exogenous reinfection may be a common mecha- 6. Styblo K. Epidemiology of tuberculosis. Bull Int Union Tuberc 1978;53:
141–52.nism by which clinical TB develops [6]. If so, global strategies
crotic areas (figure 1). There was no fever or inguinal lymphadenopa-Inflammatory Tinea Corporis Due to Trichophyton
thy. Results of a complete blood count and blood chemistry evaluationverrucosum
were normal, and the erythrocyte sedimentation rate was 13 mm/h.
Repeated skin biopsy was performed, and results of gram and acid-
A recent report by Sabota et al. describes tinea barbae due to Tricho- fast stains as well as routine bacterial and mycobacterial cultures were
phyton verrucosum in dairy farmers [1]. T. verrucosum may also cause negative. Histopathologic evaluation demonstrated a mixed inflamma-
other infections including tinea corporis [2, 3], and other animals, such tory cell infiltrate and a fungal spore (figure 1). After 2 weeks’ incuba-
as horses, may be the source of infection [4, 5]. We describe a patient, tion at 307C, T. verrucosum was isolated. Oral itraconazole (200 mg
b.i.d.) was administered for 12 weeks, and the leg lesion resolvedwith horse contact, who developed inflammatory tinea corporis due to
completely.T. verrucosum, confirmed by histopathology and culture results.
Chronic tinea corporis is uncommon and is usually due to eitherA 54-year-old man, whose work involved riding horses in rural
Trichophyton mentagrophytes or T. verrucosum [4]. T. verrucosum isareas, presented with left leg tenderness and erythema; he had no fever
distributed globally [5], and human infection has been reported pre-or other systemic symptoms. There was no response to treatment with
viously from Australasia [6, 7]. T. verrucosum usually infects cows,oral flucloxacillin and roxithromycin. A biopsy of the leg lesion was
but it is also isolated frequently from horses [4]. In the current case,performed. A gram stain of the specimen was negative, but coagulase-
the lesion was on the patient’s leg, where there had been direct contactnegative staphylococci were isolated, and histopathology demonstrated
with a common site of horse ringworm [4]. Zoophilic dermatophytesnonspecific chronic inflammatory changes with folliculitis. Treatment
like T. verrucosum may produce inflammatory disease that can bewith flucloxacillin (1 g q6h iv) and oral ciprofloxacin (750 mg b.i.d.)
mistaken for bacterial infection [1, 5, 8]. Tinea corporis due to zoophilicwas begun, but there was no improvement in the patient’s condition.
dermatophytes may resolve spontaneously, but systemic antifungalSeven weeks after his initial presentation, he was referred to our
therapy is usually required [5, 9].institution for consideration of hyperbaric oxygen therapy for ‘‘celluli-
In cases of tinea corporis, biopsies may demonstrate cylindricaltis’’ that was not responding to therapy with antibacterial agents. Exam-
fungal filaments, or rounded arthroconidia [10], which are characteristi-ination of the medial aspect of the left leg revealed a 15 1 6-cm,
cally large in T. verrucosum infection [3]. In inflammatory tinea corpo-erythematous, indurated plaque, containing pustular lesions with ne-
ris caused by zoophilic dermatophytes such as T. verrucosum, hypersen-
sitivity reactions may produce vesicles and papules accompanied by
dermal infiltrates [10], or vasculitis characterized by small follicular
papules with necrotic areas [3]. Histopathologic features of hypersensi-
tivity reactions include infiltration of lymphocytes, plasma cells, neutro-Reprints or correspondence: Dr. Tony Korman, Department of Microbiol-
phils, and eosinophils into the dermis [10].ogy, Monash University, Clayton Victoria 3168 Australia.
Tinea corporis due to T. verrucosum should be included in the
Clinical Infectious Diseases 1998;26:220–1
differential diagnosis of chronic inflammatory skin lesions in patientsq 1998 by The University of Chicago. All rights reserved.
1058–4838/98/2601–0055$03.00 with a history of contact with animals, including cows and horses.
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Figure 1. A: An erythematous, indurated plaque (15 1 6 cm), containing pustular lesions with necrotic areas on the medial aspect of the
left leg of a patient with infection due to Trichophyton verrucosum. B: Photomicrograph of biopsy specimen from a skin lesion on the patient.
A mixed inflammatory cell infiltrate in the dermis surrounds a fungal spore (arrow) that measures 10 1 12 mm. (Periodic acid–Schiff stain;
original magnification, 11,000.)
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cosilicosis, which had been diagnosed years before. Four monthsPrimary Psoas Muscle Abscess Due to Mycobacterium
before presentation, he had undergone coronary angiography andxenopi
angioplasty for ischemic coronary disease.
On examination, the patient was afebrile; he had tenderness inMycobacterium xenopi is a well-documented cause of nontuber-
the left flank but no pain on motion of either the hip or the spine.culous mycobacterial pulmonary disease, particularly in western
A chest radiograph disclosed diffuse reticulonodular infiltrates.Europe [1]. However, reports of extrapulmonary infections remain
The WBC count was within normal limits, but the erythrocyterare [2]. We present an unusual case of primary psoas muscle
sedimentation rate (ESR) was 52 mm/h, and the C-reactive proteinabscess caused by M. xenopi.
level was 8.9 mg/dL. Work-up for the left flank pain began on anA 65-year-old man presented with a 3-week history of persistent
outpatient basis and included an intravenous pyelogram, an upperleft flank pain and weight loss. His medical history included anthra-
gastrointestinal series, abdominal and pelvic ultrasonography, tho-
racolumbar spine films, and a barium enema; all results were re-
ported as normal. CT of the abdomen and pelvis revealed a large
multiloculated fluid collection in the left psoas muscle without
Reprints or correspondence: Dr. Th. Prigogine, CHU Brugmann, Place A.
bony involvement. Results of a technetium diphosphonate boneVan Gehuchten 4-1020, Brussels, Belgium.
scan were normal as well. A bronchoalveolar lavage specimen,
Clinical Infectious Diseases 1998;26:221–2
obtained to exclude tuberculosis, remained negative for acid-fastq 1998 by The University of Chicago. All rights reserved.
1058–4838/98/2601–0056$03.00 bacilli.
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Purulent material obtained by CT-guided aspiration was found PCR methods were very useful in that they allowed early detec-
tion of mycobacterial DNA and the determination of its nontuber-to be smear positive after both Ziehl-Neelsen and auramine stain-
ing. PCR detected DNA from nontuberculous mycobacteria. Cul- culous mycobacterial origin. The specific PRC technique allowed
M. xenopi identification within 24 hours after the culture becameture by use of the BACTEC system (Becton Dickinson, Cockeys-
ville, MD) revealed growth of M. xenopi, first identified by specific positive.
The optimal therapeutic regimen and duration of treatment forPCR and secondarily by biochemical testing and gas chromatogra-
phy [3]. infection due to M. xenopi are not clearly defined. In vitro suscepti-
bility tests of M. xenopi frequently show resistance to isoniazid,Antimycobacterial therapy with isoniazid, rifampin, ethambutol,
and pyrazinamide was initiated. In vitro susceptibility testing that rifampin, pyrazinamide, and ethambutol. Nevertheless, these
agents are recommended as the therapy of choice, given that previ-was performed on solid media by use of the proportion technique
of Canetti showed resistance to isoniazid, ethambutol, pyrazin- ous studies have demonstrated a poor correlation between in vitro
results and clinical responses [2–4]. The quinolones are an alterna-amide, and ethionamide. The organism was susceptible to ofloxa-
cin, rifabutin, and amikacin. tive treatment for infection due to M. xenopi.
Management of a large psoas muscle abscess requires appro-Ofloxacin was added to the patient’s therapeutic regimen when
M. xenopi was identified. Two months later, because of the enlarge- priate antibiotic therapy (usually 18–24 months), in conjunction
with percutaneous drainage or open surgical drainage. In our pa-ment of the abscess, a drainage catheter was inserted, yielding
300 mL of purulent material. Auramine staining of this material tient, the percutaneous drainage and the antibiotic therapy may not
have been completely successful because of the multiloculatedagain demonstrated acid-fast bacilli, but cultures remained nega-
tive. The abscess cavity was irrigated with povidone-iodine. Ther- nature of the abscess. We have no explanation for enlargement of
apy with pyrazinamide and ofloxacin was discontinued, and ci- the fluid collection in the context of microbiological cure and
profloxacin was added to the therapeutic regimen. improvement in the patient’s condition.
A second percutaneous drainage with lavage was performed 1
month later because there was no improvement in the patient’s Thierry Prigogine, Guy Stoffels, Maryse Fauville-Dufaux,
condition; this procedure yielded 150 mL of purulent material. Christine Trolin, and Christian Raftopoulos
Acid-fast bacilli were not detected, by either direct examination Free University of Brussels and Institut Pasteur, Brussels, Belgium
or culture.
Medical treatment was continued for 18 months, with clinical
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oides sensu stricto, Nocardia farcinica, and Nocardia nova [1];Infection Due to Nocardia farcinica in a Woman with
these organisms are responsible for 80% of cases of humanChronic Granulomatous Disease
nocardiosis [1, 2]. Nocardiosis is found predominantly (60% of
cases) in individuals with a wide variety of immunocompromis-
Nocardiosis, an infection due to an aerobic actinomycete, has ing diseases [1, 3]. Chronic granulomatous disease (CGD) pre-
a pronounced tendency toward remission and exacerbation. The disposes to infections at an early age with catalase-positive bac-
Nocardia asteroides complex comprises three species: N. aster- teria such as the Nocardia species [4]. The defect of the
phagocytic nicotinamide adenine dinucleotide phosphate
(NADPH)–oxidase complex in patients with CGD either is
present in the membrane-bound cytochrome b complex and is
Reprints or correspondence: Dr. C. A. P. Fijen, University of Amsterdam, X-linked inherited (60% of patients) or is due to autosomal
Academic Medical Centre, Department of Medical Microbiology, L1-104, inherited defects of cytosolic components p47phox (35%), p67phox
Meibergdreef 15, 1105 AZ Amsterdam, the Netherlands. (5%), or p22phox (2%–5%) [4]. Although 1.3% of the reported
Clinical Infectious Diseases 1998;26:222–4 cases of nocardiosis involve patients with CGD [1], to our
q 1998 by The University of Chicago. All rights reserved. knowledge, infection due to N. farcinica in a patient with CGD1058–4838/98/2601–0057$03.00
has not been reported; we describe such a patient.
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A 56-year-old woman with CGD and a 1-month history of fever
and a cough productive of greenish sputum failed to respond to
treatment with erythromycin. She was admitted to the hospital.
Her medical history included recurrent inguinal lymphadenitis,
pulmonary sarcoidosis, and colitis. In 1988, she was treated for
breast carcinoma. In 1994, mastitis due to infection with Aspergil-
lus fumigatus was diagnosed, and she was treated with amphoteri-
cin B; at that time, therapy was changed to that with itraconazole
because her renal function had deteriorated. CGD due to p47phox
deficiency was diagnosed. Treatment for CGD with interferon and
prophylaxis for infection with co-trimoxazole were discontinued
because of side effects.
On admission to the hospital, the patient’s temperature was
397C. Auscultation over the upper lobe of the right lung revealed
the presence of fine crackles. The erythrocyte sedimentation rate
(71 mm/h) and the WBC count (14.4 1 109/L with left shift) were
elevated, and anemia was present (hemoglobin level, 42.5 g/dL).
A chest radiograph and a chest CT scan revealed a cavernous
lesion, 7 cm in diameter, in the right upper lobe of the lung (figure
1). Bronchoscopic examination revealed no abnormalities, but
gram straining of the bronchoalveolar lavage fluid and biopsy spec-
imens showed gram-positive, filamentous and branched bacteria,
which were fluorescent with Uvitex 2B (R&R, Kandern, Ger-
many). With an assumed diagnosis of nocardiosis and consider-
ation of the amphotericin B–induced renal damage, iv cefotaxime
(1 g q.i.d.) and imipenem (500 mg q.i.d.) were administered. The
fever resolved, and, within 6 months, the pulmonary cavernous
lesion resolved.
Aerobic incubation of the bronchoscopic specimens at 377C for
4 days yielded folded, heaped, slightly orange colonies producing
an aerial mycelium. The microorganism was partially acid-fast,
was resistant to lysozyme, and produced urease and acid from
glucose and rhamnose. N. farcinica was identified on the basis of
negative decomposition of adenine, casein, xanthine, hypoxan-
thine, and tyrosine; equal growth at 357C and 457C; opacification
of Middlebrook agar; results of qualitative evaluation of cell-wall
Figure 1. Radiograph and CT scan (insert) of the thorax of a patient
mycolic and amino acids; and saccharide cell content [5]. The
with chronic granulomatous disease and infection due to Nocardia
strain was resistant to ampicillin, ticarcillin, cefoxitin, kanamycin, farcinica. A cavernous lesion developed 1 month after admission
tobramycin, gentamicin, and erythromycin; moderately susceptible (arrow).
to cefamandole and cefotaxime; but susceptible to sulfonamides,
amoxicillin/clavulanic acid, imipenem, and amikacin. Therapy
with cefotaxime and imipenem was continued because of a favor-
able response with this regimen. After 6 weeks, the therapeutic [3], but it also disseminates to the joints, kidneys, bones, and
regimen was changed to oral minocycline, 100 mg b.i.d. endocardium [2, 3, 5, 6].
Specific characteristics of species within the N. asteroides com- In our patient, the primary lesion was located in the right lung.
plex include growth at 457C for 3 days, growth on various nitrogen Lack of dissemination and the low number of infections in her
and carbon sources, and specific enzymatic activities; however, the youth may be due to the residual killing activity present in her
organism may also be identified by analysis of antibiotic resistance granulocytes. Consistent with this hypothesis, a recent report de-
patterns [1, 5]. N. farcinica is resistant to tobramycin, cefamandole, scribed residual superoxide production of the granulocytes in seven
and cefotaxime [3, 5–7]. of 11 adult CGD patients for whom the rate of infectious complica-
The lungs, brain, and traumatic and postoperative wounds were tions was low during youth [10].
the most common primary sites of infection due to N. farcinica Sulfonamides are still the treatment of choice for infections due
among 65 cases, but the paranasal sinuses, the oral palate, and the to N. farcinica [2, 3]. Good therapeutic results with monotherapy
eyes can also be involved [2, 3, 5–9]. Mouse studies demonstrate or various combinations of imipenem, amikacin, amoxicillin plus
that N. farcinica is more virulent than N. asteroides [6]. More clavulanic acid, and minocycline have also been reported [2, 3].
patients with N. farcinica infections [2, 3, 6–9] are immunocom- Combinations of imipenem and amikacin or cefotaxime and imi-
promised (70%) than are patients with N. asteroides infections [1]. penem are effective and synergistic against N. asteroides in the
mouse model [3], but for N. farcinica, such data are not available.N. farcinica has a greater tendency to disseminate [6] to the CNS
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patient suddenly became somnolent. His vital signs were: tempera-Neurosyphilis and Syphilitic Gumma of the Adrenal
ture, 102.47F; pulse, 85/min and regular; and blood pressure,Gland
84/44 mm Hg. He was resuscitated with intravenous fluids, hydro-
cortisone, and antibiotics. All cultures were negative. The cortisol
Syphilitic gummas have been described in different body organs, level at time of collapse was 18 mg/dL [2, 3], and the results of a
but syphilis of the adrenal gland is rare; only two cases were cosyntropin test were normal.
reported in the first half of this century [1]. As far as we know, Additional work-up revealed a rapid plasma reagin (RPR) titer
ours is the first case of syphilitic gumma of the adrenal gland to of 1:8,192, and a serum fluorescent treponemal antibody (FTA)
be reported in recent years.
test was positive. Serology for IgG and IgM antibodies to Borrelia
A 66-year-old male was admitted to the hospital in 1996 with a
burgdorferi was positive, but PCR assays of blood and CSF were
2-week history of abdominal pain and constipation and diminished
negative. Laboratory studies of the CSF showed a protein level of
vision in the right eye; he had had lethargy, polydipsia, and gait
96 mg/dL, a total WBC count of 55/mm3 with 94% lymphocytes,
disturbance for several months.
and a glucose concentration of 54 mg/dL (serum glucose concen-
On admission he was afebrile and had angular cheilosis and a
tration, 100 mg/dL). A CSF venereal disease research laboratory
small keratoid lesion at the right oral commissure. He was oriented
(VDRL) test was positive (titer, 1:16), and an FTA test of the CSF1 3, but his short-term memory was impaired. He had diminished
was positive. A test for antibodies to HIV was negative. The patient
central vision in the right eye, with minimal blurring of the disk
received penicillin G intravenously for 10 days. An ophthalmolo-
margins on the right. He had mild upper-extremity weakness that
gist diagnosed right-eye ischemic optic neuropathy secondary to
was more pronounced on the left than on the right. His gait was
neurosyphilis.broad based and mildly ataxic.
Left adrenalectomy was performed, revealing a 3 1 2 1 1-cmLaboratory studies revealed the following values: sodium, 137
adrenal mass with multiple hemorrhages. Microscopic examinationmEq/L; potassium, 5.2 mEq/L; chloride, 102 mEq/L; thyroxine,
of the mass revealed focal areas of necrosis with inflammatory0.82 mg/dh; and thyroid stimulating hormone, 33.86 mg/dL. A test
cells surrounded by fibrous tissue showing moderate lymphoplas-for thyroid antibodies was positive. The erythrocyte sedimentation
macytic infiltrate. A Warthin-Starry stain showed numerous spiro-rate was 140 mm/h. A CT scan of the abdomen showed a left
chetes (typical of Treponema pallidum) within the necrotic areas,adrenal mass with a central cystic area and a prominent right
confirming a diagnosis of syphilitic gumma of the adrenal glandadrenal gland. MRI of the head showed ischemic changes. Therapy
(figure 1). After the adrenalectomy was performed, the patientwith thyroxine was started after admission. Six days later, the
became lethargic; results of a repeated cosyntropin test were abnor-
mal, consistent with adrenal insufficiency [4], and replacement
therapy was started.
The clinical manifestations in our patient are consistent withThis work was presented in part at the Annual Scientific Meeting of the
neurosyphilis; the types of neurosyphilis commonly described areNew Jersey Chapter of the American College of Physicians held on 10–11
January 1997 at Long Branch, New Jersey. asymptomatic, meningeal, meningovascular, and parenchymatous,
Reprints or correspondence: Dr. Gary Gartenberg, Highland Park Medical and there is often overlap among the types [5]. Our patient’s mani-
Associates, 205 North Second Avenue, Highland Park, New Jersey 08904.
festations were predominantly those of meningovascular syphilis,
Clinical Infectious Diseases 1998;26:224–5 as manifested by memory impairment, weakness in his left upperq 1998 by The University of Chicago. All rights reserved.
1058–4838/98/2601–0058$03.00 extremity, and the ischemic optic neuropathy in association with
225CID 1998;26 (January) Brief Reports
level of 37 mg/dL, and a glucose level of 54 mg/dL; a CSF VDRL
test was negative, and the serum RPR titer was 1:128.
Our patient’s acute state of decompensation 6 days after admis-
sion was probably secondary to adrenal insufficiency precipitated
by thyroxine therapy, and the subsequent abnormal cosyntropin
test results obtained after adrenalectomy indicate syphilitic
involvement of the remaining adrenal gland. Although syphilitic
involvement of the adrenal gland was not listed as a cause of
adrenal insufficiency in a recent review [7], this condition should
be noted as a cause of adrenal insufficiency.
Noel Ilogu, Paul Daidone, Todd Stefan, Ted Louie,
Steven Deak, and Gary Gartenberg
Department of Internal Medicine, St. Peters Medical Center/
Robert Wood Johnson Medical School, New Brunswick, New Jersey
Figure 1. Warthin-Starry stain of adrenal tissue from a patient with
Referencesa syphilitic gumma of the adrenal gland showing a spirochete (arrow)
(original magnification, 11,000; oil immersion).
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sis. We present a case that illustrates the use of DNA amplificationFalse-Positive Gen-Probe Direct Amplification Test in a
that resulted in the false-positive detection of Mycobacterium tu-Case of Mycobacterium avium Complex Infection
berculosis in an HIV-positive patient for whom cultures of sputum
and blood yielded only Mycobacterium avium (MAC).Mycobacterial infection continues to be a significant disease,
A 38-year-old HIV-positive female with a history of non-with a reported 8 million new cases of tuberculosis in 1990 and
Hodgkins’ lymphoma was admitted to the hospital in July 1996300,000 cases attributable to HIV infection [1]. Despite new
with a 2-day history of pleuritic chest pain associated with fever,advances in nucleic acid technology, definitive diagnosis still relies
chills, and a productive cough yielding yellowish sputum; findingsprimarily on microscopy and culture. Recent developments in the
on a chest radiograph were normal. HIV infection had been diag-area of DNA and RNA amplification have allowed the rapid detec-
nosed 1 month before admission, and she had no history of anytion of mycobacterial nucleic acids directly in clinical samples.
AIDS-defining illnesses or any antibiotic or antiretroviral therapy.Although this new technology promises more rapid diagnosis than
Her last total absolute lymphocyte cell count, obtained 1 monthits standard counterparts, which depend on the slow growth of
before, was 308/mm3, and her last CD4 lymphocyte count was
acid-fast bacilli (AFB), such a tool in its early stages should be
108/mm3.
used with discretion, especially when it is used as a tool for diagno-
During hospitalization, she remained febrile despite treatment
with ticarcillin/clavulanate, vancomycin, and trimethoprim-
sulfamethoxazole. Blood and sputum were evaluated for mycobac-
terial infection, and one of four sputum samples was positive on
Reprints or correspondence: Dr. Marcus J. Zervos, William Beaumont Hos-
auramine-rhodamine staining (6–10 bacilli per high-power fieldpital, 3601 West 13 Mile Road, Royal Oak, Michigan 48073.
were detected). Samples were evaluated by using the rRNA ampli-
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1058–4838/98/2601–0059$03.00 Direct Test (AMTD) system (Gen-Probe, San Diego, CA). The
226 Brief Reports CID 1998;26 (January)
AMTD yielded a value of 81,099 relative light units (RLU). Ac- AMTD values of 30,000–100,000 RLU, especially in the presence
cording to the manufacturer’s specification, values ⁄30,000 RLU of MAC, should therefore be interpreted with extreme caution.
are indicative of a positive test, thereby establishing the presence
of M. tuberculosis. Although none of the initial or follow-up blood Eileen D. Javellana and Marcus J. Zervos
cultures ever yielded M. tuberculosis, they did, however, yield Department of Medicine, William Beaumont Hospital, and Wayne State
MAC. In addition, when the initial sputum sample used for the University School of Medicine, Detroit, Michigan
AMTD was cultured, it also yielded MAC.
Comparative DNA analyses of M. tuberculosis and MAC have
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despite a recent study of the Gen-Probe AMTD in which 100% nary M. kansasii infection [abstract LB19]. In: Program and abstracts of
sensitivity and 99.3% specificity were found [3], it is clear that the 36th Interscience Conference on Antimicrobial Agents and Chemo-
this was not the case for the patient described above. Other investi- therapy (New Orleans). Washington, DC: American Society for Microbi-
ology, 1996.gations have reported similar observations [4]. Low-level positive
ROIs by phagocytic respiratory burst may play a role in the defenseThe Role of Phagocytic Respiratory Burst in Host
of the host against M. tuberculosis.Defense Against Mycobacterium tuberculosis
Between January 1988 and December 1996, we diagnosed CGD
in 11 young Chinese males on the basis of the absence of reduction
Tuberculosis is a major cause of morbidity and mortality world- of nitroblue tetrazolium. The clinical features of six of these pa-
wide [1]; however, the mechanisms by which host phagocytic cells tients have been reported previously [5]. Mutations of the gp91phox
defend against Mycobacterium tuberculosis remain obscure. Chan gene were defined for seven of the eight patients who are alive,
et al. implicated reactive nitrogen intermediates (RNI) as the prin- thereby establishing the diagnosis of X-linked CGD [6]. Our re-
cipal mechanism responsible for the destruction of M. tuberculosis view of the clinical courses of these 11 patients represents a total
by murine macrophages [2]. Further, by demonstrating that the observation period of 75 patient-years. Three of the 11 patients
oxygen radical scavengers, superoxide dismutase (SOD) and cata- died at 1.4, 0.4, and 0.3 years of age. Two died of infection due
lase, have no effect on the antimycobacterial activity of macro- to Pseudomonas species, and one died of infection due to Esche-
phages, these authors suggest that the involvement of reactive richia coli. The mean age of the remaining eight patients was 9
oxygen intermediates (ROI) in the killing of M. tuberculosis is years (range, 1.9–21.4 years). Of the eight survivors, six had recur-
unlikely [2]. Patients with chronic granulomatous disease (CGD) rent, intractable tuberculosis (table 1).
have a defect in the nicotinamide adenine dinucleotide phosphate The index case for patients 1 and 2, who are brothers, was their
(NADPH) oxidase pathway that renders neutrophils incapable of father, who had smear-positive pulmonary tuberculosis. Patient 2
generating oxygen radicals. Jones et al. demonstrated that CGD also had multiple splenic abscesses, most likely of tuberculous
neutrophils are as capable of decreasing the viability of M. tubercu- origin, at the time of his second episode of pulmonary tuberculosis.
losis as are normal neutrophils, thereby concluding that the killing Resolution of the splenic abscesses was more rapid than that of
of M. tuberculosis is independent of the oxygen metabolic burst the pulmonary lesions, for which right middle lobectomy was even-
[3]. In addition, M. tuberculosis has not been described as a major tually required. At the time the cases were reported, the patients
pathogen in patients with CGD in the United States [4]. Despite this had been receiving anti-tuberculous treatment for 3 years and
conventional view, we have clinical evidence that the generation of IFN-g for the last few months. The M. tuberculosis isolate from
patient 1 was susceptible to first-line anti-tuberculous agents. How-
ever, the pulmonary lesions of the two brothers responded poorly
to treatment; there were persistent changes evident on chest radio-
graphs. Patients 3, 4, and 5 had recurrent tuberculous infections
Financial support: the CRCG of the University of Hong Kong. that responded to treatment for 9 months to 1 year with standard
Reprints or correspondence: Dr. Y. L. Lau, Department of Paediatrics, Queen
anti-tuberculous regimens. Shadows evident on chest radiographsMary Hospital, Pokfulam Road, Hong Kong.
were slow to resolve, suggesting an exaggerated inflammatory
Clinical Infectious Diseases 1998;26:226–7
response. Patient 5 also presented with calcified left axillary lymphq 1998 by The University of Chicago. All rights reserved.
1058–4838/98/2601–0060$03.00 node at 6 months of age, most likely due to vaccination with BCG,
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Table 1. Characteristics of tuberculous infections in six patients with chronic granulomatous disease.
Patient no. Age (y) Site involved Diagnostic methods, results
1 6.1 Lung CR, MT
7.3 Lung CR; buffy coat culture yielded Mycobacterium
tuberculosis
2 4.7 Lung CR, MT
7.7 Lung CR, MT; lobectomy specimen showed
granulomatous histology
3 3.3 Axillary lymph node AFB seen on excision biopsy
5.0 Lung CR; gastric aspirate culture yielded
M. tuberculosis
4 7.3 Lung CR, MT
9.8 Lung CR; AFB seen in bronchoalveolar lavage
specimen
5 1.5 Lung CR, MT
3.3 Lung CR, MT
6 7.5 Lung CR; gastric aspirate culture yielded
M. tuberculosis
17 Lung CR; sputum culture yielded M. tuberculosis
21 Cervical lymph node AFB seen on biopsy
NOTE. AFB  acid-fast bacilli; CR  chest radiograph; MT  Mantoux test.
which is administered to all infants born in Hong Kong. Patient sis is high; this combination of events allows us to infer that
6, who is now 20 years old, had three episodes of tuberculous phagocytic respiratory burst plays a role in host defense against
infections that responded only to prolonged anti-tuberculous treat- M. tuberculosis.
ment. The severity and recurrent nature of their tuberculous condi-
tions suggest that the ability to destroy M. tuberculosis may be Y. L. Lau, G. C. F. Chan, S. Y. Ha, Y. F. Hui,
impaired in patients with CGD. and K. Y. Yuen
In recent years, the annual incidence of tuberculosis in Hong Departments of Paediatrics and Microbiology,
Kong has been 100 cases per 100,000 population [7]; however, University of Hong Kong, Queen Mary Hospital, Hong Kong
the annual incidence among our patients with CGD was 13 epi-
sodes over 75 patient-years (i.e., 17,333 cases per 100,000 popula-
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